Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2026-02-23 @ 12:20 PM
Study NCT ID:
NCT04136366
Status:
COMPLETED
Last Update Posted:
2025-07-09
First Post:
2019-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
Sponsor:
Aldeyra Therapeutics, Inc.
Organization: